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p53 stabilityThe differentiation from constantly dividing epithelial cells into secondary ﬁber cells is a key step during lens de-
velopment. Failure in this process, which requires cell proliferation inhibition and cell cycle exit, causes cataract
formation. HSF4 (Heat Shock Transcription Factor 4) genemutationsmay lead to both congenital and senile cat-
aract. However, how HSF4 mutations induce cataract formation remains obscure. In this study, we demonstrate
thatHSF4 can suppress the proliferation of human lens epithelial cells (HLECs) bypromotingG1/S arrest in a p53-
dependent manner. In contrast, HSF4 with cataract causative mutations fail to cause cell cycle arrest and have no
obvious effect on cell proliferation. We further identify that HSF4 recruits p53 in the nucleus and promotes its
transcriptional activity, leading to the expression of its target gene p21 in HLECs. HSF4, but not its cataract-
causing mutants, stabilizes p53 protein and inhibits its ubiquitin degradation. Our data reveal that HSF4 may
work as a switch between lens epithelial cell proliferation and secondary ﬁber cell differentiation, a process
which mainly depends on p53. Through demonstration of this novel downstream pathway of HSF4, our results
help uncover the pathogenic mechanisms caused by HSF4 mutations.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cataract is deﬁned as lens opacities. It is a major ocular disease that
leads to blindness inmany cases [1,2]. It is usually caused by the defects
in the development and physiology of the lens and its surrounding ocu-
lar tissues [3]. The lens comprises of two types of cells, the lens epithelial
cells and the lens ﬁber cells, the latter of which form the bulk of the in-
terior of the lens. The lens epithelial cells reside only on the anterior side
of the lens. Cells residing in the epithelial region just above the lens, glyceraldehyde-3-phosphate
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, lium@mail.hust.edu.cnequator undergo elongation and differentiation into new ﬁber cells con-
tinuously throughout whole lifespan [4]. During the differentiation pro-
cess, lens epithelial cells undergo dramatic morphological changes
including exiting from the cell cycle, proliferation inhibition, migration,
cell elongation, and elimination of nuclei and other organelles, accom-
panied by the increase in ﬁber-speciﬁc proteins. An elaborately orches-
trated balance of cell cycle progression, proliferation and differentiation
is necessary to maintain the unique function of the lens epithelial cells.
However, themolecularmechanisms of regulating the transition of pro-
liferating lens epithelial cells to differentiated lens ﬁber cells are still
unrevealed.
HSF4 belongs to the family of heat shock transcription factors
(HSFs), which regulates the expression of heat shock proteins (Hsps)
in response to different stresses [5]. Unlike other HSFs, HSF4 does not
contain the HR-C domain, which is necessary for the suppression of tri-
mer formation [6]. The mammalian HSF4 generates two proteins by al-
ternative splicing, the repressor HSF4a and the activator HSF4b. Both
HSF4a and HSF4b exist as trimers and bind to heat shock elements
(HSEs) constitutively [7], but only HSF4b is expressed in the lens [8].
HSF4 is an essential transcriptional regulator during lens development.
The expression of HSF4 begins at E13.5 and reaches a peak early after
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lens elongate and differentiate to form the primary ﬁber cells [4,
9]. Histological studies on HSF4-knockout mice demonstrated ab-
normalities in lens development, including defects in ﬁber cell dif-
ferentiation and early cataract formation [9–11]. HSF4 was ﬁrst
identiﬁed to be a causative gene for congenital cataract in 2002
[12]. Five mutations in the DNA binding domain (A20D, K23N,
R74H, L115P and R120C) of HSF4 have been characterized to be re-
lated to chromosomal dominant hereditary cataract [12–15]. HSF4
gene mutations also cause autosomal recessive congenital and age-
related cataracts [16–19], among which a newmutation Arg116His
in the DNA binding domain has been associated with age-related
cataract recently [20]. However, how these mutations affect HSF4
function remains unclear.
HSF4 has been shown to be involved in cell growth. Overexpres-
sion of HSF4 affected cell growth. HeLa cell lines that stably
expressed variable levels of hHSF4 showed different division rates
[6]. HSF4 is required for normal cell growth and differentiation dur-
ing mouse lens development. In HSF4 knockout mice, lens epithelial
cells showed abnormal proliferation and premature differentiation.
The numbers of epithelial cells increased in 2 days postpartum, and
BrdU-positive cells in the epithelial layer increased in E18.5 mice [9].
As a key regulator of cell growth and death, p53 controls cell cycle
progression and apoptosis under particular conditions [21]. These
processes are critical for cell function and frequently participate in
tumor inhibition [22,23]. All steps involved in p53 regulation are strictly
monitored by the sensing and executing machineries in cells [21]. p53 is
a short-lived protein and is maintained at a very low level in normal
cells under no stress, and shuttles between the nucleus and the
cytoplasm depending on the cell cycle [24]. In response to stress, p53
tends to accumulate in the nucleus, which is critical for its stability and
activity [25]. It inhibits cell growth by inducing cell cycle arrest, mainly
by transcriptional activation of its target genes. p21 (WAF1/CIP1), one
of the important target genes of p53, is also a common inhibitor of
cyclin-dependent kinases and can alter cell cycle progression in various
kinds of cells [26,27].
In addition to its role as a tumor suppressor, p53 has been implicated
as an important protein in cell proliferation and differentiation during
embryonic lens development [28]. Both the Rb and p53 inactivated
transgenic mice exhibited cataracts. Analysis of the lens from these
transgenic mice revealed that lens epithelial cell proliferation is induced
in inappropriate regions and lens ﬁber cell fails to denucleate. It is
necessary for p53 to regulate exit from the normal cell division cycle in
differentiating lens ﬁber cells [29]. The proper expression level of p53
plays a key role in differentiating tissues. Transgenic mice expressing
wild type human p53 developed microphthalmia as a result of a
defect in ﬁber formation. In the lens of these transgenic mice, epithe-
lial cells showed apoptosis and failed to undergo proper differentia-
tion [30]. Liu et al. demonstrated that p53 directly regulates both c-
Maf and Prox-1 to control lens differentiation [31]. More recently, Ji
et al. showed that p53 controls expression of αA and βA3/A1-
crystallin gene expression [32]. In addition, Hu et al. provided critical
evidence that p53 regulates the γA-crystallin gene during mouse lens
development [33]. p53-Bak apoptotic signaling axis plays an essential
role in regulating lens differentiation. Knockdown of p53 suppresses
bFGF-induced differentiation of the lens epithelial cells in vitro [34].
These results suggest that p53 participates in lens differentiation.
Nevertheless, it is unclear whether there was any crosstalk between p53
and HSF4-mediated lens differentiation.
In the present study, we demonstrated that HSF4 inhibited lens
epithelial cell proliferation by stabilizing p53 protein and promot-
ing G1/S arrest. However, HSF4 cataract causative mutations had
no effect on cell proliferation and p53 stabilization. Our ﬁndings
have implicated a clear molecular mechanism of how HSF4 partic-
ipated in the critical progress of the transition of lens epithelial
cells into ﬁber cells.2. Materials and methods
2.1. Plasmids, cell culture and transfection
The human lens epithelial cell line used in this study was immortal-
ized from primary cultures through transfection with SV40 large T anti-
gen [35], and the human lens epithelial cells (HLECs) were cultured in
Dulbecco's modiﬁed Eagle's medium (DMEM, Gibco) containing 10%
fetal bovine serum (FBS, Gibco). The human lung carcinoma cell line
H1299 was also maintained in DMEM supplemented with 10% FBS.
The whole length of HSF4 cDNA was obtained from HLECs by reverse
transcription-PCR and cloned into pEGFP-N1, pCMV–Myc and pGEX-
4T-1 plasmids. All HSF4 mutations were introduced by the QuikChange
site-directed mutagenesis kit (Agilent Technologies). The whole length
of p53 cDNAwas also obtained from the HLECs, and cloned into pCMV–
FLAG plasmid. Plasmids were transfected into HLECs with
Lipofectamine® 2000Reagent in Opti-MEM® I Reduced SerumMedium
(Invitrogen) and incubated for 4 to 6 h. After 24 or 36 h, cells were col-
lected for RNA and protein extractions.
2.2. Small interfering RNA (siRNA)
HSF4-speciﬁc siRNAs were purchased from RiboBio, China, using
their RNAi design center. The siRNA duplexes are HSF4 No1; 5′ GCAA
GCUGAUCCAGUGUCU 3′ No2; 5′ CGCCAACUCAACAUGUACG 3′. Stealth
RNAi negative control was used as a Negative Control (NC). HLECs
were plated at 24-well tissue culture plates 20 to 24 h before transfec-
tion. For transfection of siRNAs, cells at 30–50% conﬂuency were
transfected with 100 nM of siRNA using 1 μL Lipofectamine® 2000 for
each well. The cells were harvested 48 h after transfection. For p53 pro-
tein half-life assay, after plasmids or siRNA transfection, cells were
added 0.5 μg/ml cycloheximide (CHX, Beyotime China), then harvested
at different time points separately.
2.3. Immunoﬂuorescence and confocal microscopy
Cells were ﬁxed in 4% paraformaldehyde and permeabilized with
0.5% Triton X-100 for 15 min. After being blocked with 5% BSA in PBS
for 1 h, cells were incubated with primary antibody overnight at 4 °C.
p53 was detected using a polyclonal antibody against p53 (1:2000,
Proteintech), then incubated for 1 hwith the secondary antibody conju-
gated with Alexa Fluorescence 568 (1:1000, Invitrogen) in 37 °C. Nuclei
were stainedwithDAPI (1:5000, Sigma). Cellswere visualized by confo-
cal ﬂuorescence microscopy (Leica TCS SP2 AOBS MP Microscope
system).
2.4. Western blot
Cellswere lysedwith IP cell lysis buffer (Beyotime, China)with cock-
tail protease inhibitors (Roche). The protein samples were separated by
12% SDS-PAGE and transferred to nitrocellulose membranes. The mem-
branes were blocked with 5% skimmilk for 2 h and incubated with pri-
mary antibodies overnight at 4 °C. The primary antibodies were as
follows: a rabbit polyclonal antibody against HSF4 (1:2000, produced
by Abmart) [36], a rabbit polyclonal antibody against p53 (1:2000,
Proteintech), a rabbit polyclonal antibody against p21 (1:2000, Epi-
tomics), a rabbit polyclonal antibody against GAPDH (1:4000,
Proteintech), a rabbit polyclonal antibody against GFP (1:2000,
Proteintech), a mouse monoclonal antibody against FLAG (1:5000,
MBL), a mouse monoclonal antibody against α-tubulin (1:2000,
Millipore). The primary antibodies were probed with either a goat
anti-rabbit or a goat anti-mouse HRP-conjugated secondary antibody
(1:20,000, Thermo). Signals were detected using a ChemiDoc XRS
(Bio-Rad),with SuperSignal Sensitivity Substrate (Thermo), andquanti-
ﬁed with Quantity One software (Bio-Rad Laboratories).
1810 M. Huang et al. / Biochimica et Biophysica Acta 1853 (2015) 1808–18172.5. Pull-down, immunoprecipitation and ubiquitination assays
HSF4 constructs were expressed in Escherichia coli strain BL21
and the fusion proteins were induced by 1 mM isopropyl–thio-
galactopyranoside (IPTG, Sigma). Then fusion proteins were puri-
ﬁed with GST-SepharoseTM 4B beads (GE Healthcare Life Science)
according to the standard manual, and then incubated with the
HLECs lysates in 4 °C for 2 h. SDS-PAGE was performed on the
pull-down products and results were detected with immunoblot-
ting and Coomassie blue staining.
For immunoprecipitation, GFP-tagged wild type (WT) and mutated
HSF4 plasmids were co-transfected into HLECs with pCMV-FLAG-p53
plasmid respectively, after 36 h, cells were lysed in IP buffer by rotating
at 4 °C for 30min. The lysate was centrifuged at 4 °C for 10min, and the
supernatant was incubated with 2 μg of antibodies against GFP
(Proteintech, China) or FLAG (MBL) at 4 °C for 8 h, using the mouse
and rabbit IgG as a negative control. The Protein G Sepharose 4 Fast
Flow (GE Healthcare Life Science) was added and rotated at 4 °C for an-
other 2 h. Then the pelletwaswashed three timeswith 1mL lysis buffer.
The ﬁnal pellet was suspended in sample buffer and utilized in SDS-
PAGE and immunoblotting.
For ubiquitination assays, HLECs were transiently transfected with
HSF4 plasmids, and treated for 6 h withMG132 (10 μM) before harvest.
The cell extracts were immunoprecipitated with p53 polyclonal anti-
body overnight at 4 °C. The Protein G Sepharose 4 Fast Flow was
added and rotated at 4 °C for another 2 h. Then the pellet was washed
three times with 1 mL lysis buffer. The samples were resolved by 8%
SDS-PAGE gels for western blot analysis with antibody against ubiquitin
(UB, 1:1000, Proteintech, China).2.6. Flow cytometer analysis
HLECs were planted in 6-well tissue culture plates. The GFP vector,
GFP-HSF4 WT and mutant type (A20D, R74H and L115P) vectors were
transfected transiently. The NC and HSF4-speciﬁc siRNAs were
transfected into cells and harvested after 48 h. Cells were collected
and washed twice with PBS, then ﬁxation was done by the addition of
70% cold ethanol and incubated overnight at −20°C, then washed
twice with PBS and the cells were suspended into 500 μL of PBS. After
being pretreated with 50 μg/mL of RNaseA (Beyotime, China) for
30 min at 37 °C, cells were stained by addition of 50 μg/mL propidium
iodide (Sigma) for 20 min in dark at room temperature. Cell cycle anal-
ysis was carried out using FACS ﬂow cytometer (Beckman). Only the
GFP positive cells were analyzed in the HSF4 overexpression assay.
Cell cycle proﬁles were analyzed using FlowJo cytometry analysis soft-
ware (version 7.6). This process sometimes can lead to percentages
that add up to a little more or a little less than 100%, particularly in
the sub-G0/G1 or super G2/M populations.2.7. EdU proliferation assay
5-Ethynyl-2′-deoxyuridine (EdU) efﬁciently incorporates into
replicating DNA as a labeling method to replace 5-methyl-2′-
deoxyuridine (thymidine). HLECs were cultured in 24-well plates
and transfected with siRNAs and indicated plasmids. EdU nuclear
staining reaction was detected by Cell-Light TM EdU proliferation
assay detection kit (RiboBio, China). The staining reaction was per-
formed according to the standard protocol after transfection. The
signal was obtained from the ﬂuorescence microscope (Leica TCS
SP2 AOBS MP). For over expression experiment, the EdU-labeled
cells of each 100 GFP positive cells in three different ﬁelds were
counted. For HSF4 interference, the percentages of EdU-positive
cells in three different ﬁelds were counted, and each ﬁeld contains
1000 cells at least.2.8. Real-time qPCR
Cells were treated with Trizol (Invitrogen), and the total RNAs were
obtained by phenol chloroform extraction. RNA (2 μg) was used for
generating cDNA by MMLV reverse transcriptase (Invitrogen) in a
20 μL reaction according to manufacturer's instruction. cDNA were
used in a 10 μL real time PCR reaction in triplicate. SYBR® Green PCR
Master Mix (Roche) was used in the reactions to enable melting-point
analysis with ABI 7900HT Real-time PCR System. The primers as
follows:
actin 5′-tgacgtggacatccgcaaag-3′ and 5′-ctggaaggtggacagcgagg-3′,
p21 5′-cggcggcagaccagcatgacaga-3′ and 5′-cgcgcttccaggactgcaggctt-
3′,
p53 5′-ggcccatcctcaccatcatcaca-3′ and 5′-tgcgccggtctctcccagga-3′,
HSF4 5′ gagatacctgacagggggcctctg 3′ and 5′
ggaaccaagggctgcatcaaggac 3′.
2.9. Dual luciferase reporter assays
HLECs were cultured in 24-well plates and transfected with 250 ng
wild type, and mutant HSF4 plasmids and p53-luciferase (p53-Luc)
reporter plasmid (Stratagene), together with 40 ng of pRL-TK vector
containing renilla luciferase (Promega). Cells were harvested 36 h
later and the dual luciferase activitywas detected according to theman-
uscript of Dual-Luciferase Assay system (Promega) by ﬂuorescence
spectrometer (Promega). The ﬁreﬂy luciferase activity was normalized
to renilla luciferase activity, and the results were analyzed using
SPSS19.0.
2.10. Statistical analysis
All experimentswere repeated at least three times.Mean values±S.
E. were calculated and used to test for signiﬁcance between treatments
in each dataset using the Student's t test. Differences were considered
signiﬁcant when *, p b 0.01.
3. Results
3.1. HSF4, but not its mutants, inhibits HLECs proliferation and regulates
G1/S transition
HSF4 knockoutmice exhibited increased proliferation of lens epithe-
lial cells and premature differentiation of lens ﬁber cells [9], suggesting
that HSF4 plays a key role in cell proliferation. To examine whether
HSF4 mutations could affect the proliferation of human lens epithelial
cells, plasmids of GFP-HSF4 and three HSF4 cataract causative mutants
(GFP-A20D, R74H and L115P) were transiently transfected into HLECs
for thirty-six hours. Cells were then subjected to EdU proliferation
assay. The ratio of EdU incorporation was determined by the
formula = dual positive signal (EdU/GFP) / total GFP signal (Fig. 1A).
Unlike GFP vector control and mutants, the EdU incorporation signals
were rarely found in wild type HSF4-transfected cells, suggesting that
wild type HSF4 obviously inhibited the HLECs proliferation, while all
three mutants showed slight inhibition (Fig. 1B). Cell cycle progression
is an essential process by which the cell monitors its growth and
differentiation, it is very important in the lens epitheliumwhen it begins
to differentiate into ﬁber cells [37]. Thirty-six hours after transfection of
HSF4 relevant plasmids into HLECs, cell cycle distribution was
performed using FACS. Only GFP positive cells were analyzed. A
comparative analysis revealed that wild-type HSF4-transfected cells
displayed a striking decrease of the number of cells in the S and G2/M
phases (from 19.03% to 5.91%, from 14.67% to 6.44%, respectively),
compared to control. HSF4-transfected cells arrested in G0/G1 phase in-
creased from 67.45% to 89.91%. In contrast, formutant HSF4-transfected
Fig. 1.HSF4 inhibits HLECs proliferation and regulatesG1/S transition. (A)Wild type (WT)HSF4 inhibits HLECs proliferation. GFP taggedWTandmutantHSF4were transfected intoHLECs.
GFP empty vectorwas used as control. 36 h after transfection, cellswere subjected to EdUproliferation assay.White arrows indicate the EdU-incorporation cellswith GFP signals, Scale bar:
30 μm. (B) The ratios of cell proliferation are shown in the histogram. EdU-labeled cells of each 100 GFP positive cells were counted in three different ﬁelds for every sample. It was de-
terminedby the formula=dual positive signal (EdU/GFP) / total GFP signal, normalized by the control. The overexpression of HSF4 proteinswere conﬁrmed bywestern blot shown below
the ﬁgure. (C) Cell cycle analysis in WT and mutant HSF4 transfected HLECs was carried out using a FACS ﬂow cytometer. Only GFP-positive cells were sorted. HSF4-transfected cells
arrested in G0/G1 phase increased from 67.45% to 89.91% compared to control. (D) The cell proportion in each phase was shown. The overexpression of HSF4 proteins was also conﬁrmed
bywestern blot shownbelow theﬁgure. Three independent experimentswereperformed. Signiﬁcant differencebetween control andWTHSF4 transfected cells inG0/G1phaseproportion
were analyzed and indicated. (E) The interference effectiveness ofHSF4 siRNAswas tested. HSF4mRNA levelswere assayed byqPCRafter transfectionwith twopairs of siRNA andnegative
control (NC). The relative mRNA levels were normalized to β-actin. Three independent experiments were performed. (F) Ablation of HSF4 reduces the G0/G1 phase proportion in HLECs.
Cell cycle analysis in HSF4 siRNAs transfected HLECs was carried out using a FACS ﬂow cytometer. The G0/G1 phase cells were decreased from 75.32% to 62.67% and 68.89%. (G) The cell
proportion in each phasewas shown. Three independent experiments were performed. Signiﬁcant difference between negative control and HSF4-siRNAs transfected cells in G0/G1 phase
proportion were analyzed and indicated. Error bars represent standard deviation (SD). *, p b 0.01.
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tered when compared with control (from 67.45% to 65.3%, 60.7% or
59.56%) (Fig. 1C, D).
To further conﬁrm the role of endogenous HSF4 in cells growth and
underlying molecular mechanisms, HLECs were transfected with two
pairs of siRNA to silence endogenous HSF4. Because the low protein
level of HSF4 in the HLECs and limitation of HSF4 antibodies sensitivity,
the endogenous HSF4 was not sufﬁcient to be detected by western blot
(data not show).We detected theHSF4mRNAby qPCR instead (Fig. 1E).
Moreover, we usedHSF4 overexpressed HLECs to perform siRNA exper-
iment, and the results showed remarkable knockdown effect, too. Al-
though both siRNA could knockdown endogenous HSF4, siRNA-1
showed higher efﬁciency (Fig. S1). We also detected the proliferation
of HSF4 knockdown cells. Forty eight hours after transfection, cells
were subjected to EdUproliferation assay. HLECswithHSF4 knockdown
showed increased proliferation rate (Fig. S2A), whichwas raised at least
two folds compared to those treatedwith control siRNA (Fig. S2B). Thenthe cell cycle progression was checked in the HSF4 interfered HLECs.
Forty eight hours after transfection, HLECs were collected and sorted
by FACS (Fig. 1F). The G0/G1 phase proportion was decreased in cells
transfected with both HSF4 siRNAs (Fig. 1G). In agreement with siRNA
knockdown efﬁciency, the G0/G1 phase cells were decreased from
75.32% to 62.67% after siRNA-1 transfection, and to 68.89% after
siRNA-2 transfection. Thus, the increased proliferation rate of HLECs
was due to accelerated cell cycle progression. Above all, these observa-
tions implied that HSF4 may function in G1/S cell cycle arrest and
control of cell proliferation, which are critical preludes of cell differenti-
ation. Nevertheless, HSF4 cataract causative mutants failed to cause cell
cycle arrest and had no obvious effect on cell proliferation.
3.2. HSF4 causes cell cycle withdrawal in a p53 dependent manner
Thep53protein, a key regulator of cell growth and death, also partic-
ipates in differentiation and development [28,38,39]. HSF1, another HSF
Fig. 2.HSF4-induced cell cyclewithdrawal is p53 dependent. (A)GFP taggedWT andmutantHSF4were transfected into p53-null cell lineH1299. Cell cycle analysiswas carried out using a
FACS ﬂow cytometer. Only GFP-positive cells were sorted. The proportion of G0/G1 phase in HSF4-transfected cells was no change compared to control. (B) The cell proportion in each
phases was shown. The overexpression of HSF4 proteins was conﬁrmed by western blot shown below the ﬁgure.
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cycle arrest in response to genotoxins [40]. To investigate whether
HSF4-mediated cell cycle inhibition is p53 dependent, wild type and
mutant HSF4 were transiently transfected in the p53-null cell line
H1299, then the cell cycle distribution was detected by ﬂow cytometry,
only GFP positive cells were analyzed (Fig. 2A). HSF4 was unable to in-
duce a G1/S arrest when p53 was absent (Fig. 2B). The expression of
HSF4 proteins in H1299 was checked by western blot (Fig. 2B). Further
conﬁrmation of the proliferation was detected in H1299. The cells were
subjected to EdU proliferation assay (Fig. S3A). HSF4 overexpression
failed to change the cell proliferation rate of H1299 cells (Fig. S3B),
but not in p53 constructive expressive HLE cell-lines. In HLECs, HSF4
causes G1/S transition and markedly proliferation inhibition. However,
in p53 null H1299 cells, it could not cause such effect. Taken together,
our results suggested that HSF4 reduced lens epithelial cells growth de-
pending on the p53 pathway.3.3. HSF4 co-localizes and interacts with p53
Since HSF4-regulated cell cycle progression is p53-dependent, we
hypothesized that p53 may interact with HSF4. We ﬁrst investigated
the localization of HSF4 and p53 protein in HLECs. GFP-HSF4 and its
three cataract causative mutants (GFP-A20D, R74H and L115P) were
transiently transfected into HLECs. Confocal microscopy showed that
both wild and mutant type HSF4 localized in nucleus (Fig. S4). HSF4 re-
cruited endogenous p53 and they accumulated as speckles together in
the nucleus. However, unlike wild type HSF4, three mutants (A20D,
R74H and L115P) showed diffuse distribution in the nucleus, and
there were only very small amounts of endogenous p53 co-localized
with HSF4 mutants. The results suggested that wild-type HSF4, but
not its mutants, regulated the distribution patterns of p53 (Fig. 3A). To
investigate whether HSF4 interacts with p53, co-immunoprecipitation
assay was employed. GFP-tagged HSF4 expression vector and FLAG-
tagged p53 expression vector were co-transfected into HLECs. GFP-
HSF4 was immunoprecipitated by GFP antibody, and p53 was clearly
detected in the anti-GFP pellet. In a reciprocal experiment, HSF4 was
found in the anti-FLAG-p53 immunoprecipitate (Fig. 3B). To determine
whether HSF4 directly interacts with p53, we performed pull-down
assay using GST-HSF4 fusion proteins expressed in E. coli. Coomassieblue staining showed the bait proteins GST-HSF4 fusion protein.
HLECs lysates were separately passed through the GST (negative con-
trol) or GST-HSF4 fusion protein column. GST-HSF4 but not GST alone
efﬁciently pulled down p53 (Fig. 3C). Furthermore, the GFP tagged
HSF4 mutants and FLAG-p53 plasmids were co-transfected into HLECs
for immunoprecipitation assay. Although all theHSF4 proteins could in-
teract with p53, HSF4 wild type showed the highest binding ability
(Fig. 3D). Our results showed that wild-type HSF4 strongly interacted
with p53 to change its nuclear distribution. Although p53 could interact
with all the three mutations, the interactions are decreased along with
its diminished nucleus location.
3.4. Wild type but not mutant HSF4 up-regulates p53 protein level
As p53 is a key regulator of cell growth and death, the regulation of
p53 itself is elaborate. To examine whether the interaction between
HSF4 and p53 affect p53 expression, the protein level of p53was detect-
ed inHLECs transfectedwithwild type andmutant HSF4.We found that
p53 is accumulated in wild type HSF4 transfected cells, but not in mu-
tant HSF4 transfected cells (Fig. 4A). Compared to the control vector,
the HSF4 overexpression signiﬁcantly increased p53 protein expression
by about two folds (Fig. 4B). We next examined whether the up-
regulation of p53 was caused by increased mRNA level. However,
qPCR results showed no signiﬁcant alterations at p53 mRNA levels
(Fig. 4C). In agreement with this, the p53 protein was signiﬁcantly de-
creased when HSF4 was silenced (Fig. 4D, E). The p53 mRNA levels
were still unchanged in both pairs of HSF4 siRNA transfected cells
(Fig. 4F). The interference efﬁciency of siRNAs against HSF4 was also
checked by qPCR (Fig. S5). These results further indicated that HSF4
up-regulates p53 protein level, HSF4 cataract-causative mutants
(A20D, R74H and L115P) fail to do so.
3.5. HSF4, but not its mutants, stabilizes p53 protein by inhibiting its
ubiquitination and degradation
HSF4 up-regulating p53 protein but not its mRNA motivates us to
ask whether the accumulation of p53 relies on its protein stability. To
this end, CHX, an inhibitor of protein biosynthesis in eukaryotic cells,
was added into cells at 0.5 μg/ml. HLECs are sensitive to CHX compared
Fig. 3.HSF4 co-localizes and interacts with p53. (A) HSF4 co-localizes with p53. GFP taggedWT andmutant HSF4 (Green) were transfected into HLECs. p53 was analyzed by immunoﬂu-
orescence with an antibody against p53 (Red). The p53 protein distribution showed strong association with WT HSF4 in speckled structure. Scale bar: 10 μm. (B) Ectopically expressed
HSF4 and p53 interact with each other. HLECs were co-transfected with GFP-tagged HSF4 and FLAG-tagged p53 expression plasmids. Cell lysates were subjected to immunoprecipitation
(IP) with anti-GFP or anti-FLAG antibody followed by immunoblotting with FLAG or GFP antibody. Rabbit and mouse IgG were used as negative controls. (C) HSF4 interacts with p53
in vitro. The direct interaction between p53 and HSF4 was detected by the GST-pull down assay. Puriﬁed GST alone or GST-tagged HSF4 proteins immobilized on GST-Sepharose beads
was incubated with HLECs lysates. Bound p53 was detected by western blot (upper panels). Recombinant GST and GST-HSF4 proteins were visualized by Coomassie blue staining
(lower panels). ** Likely p53 degradation product. (D) The interaction between mutant HSF4 and p53 is diminished. The GFP tagged wild type and mutant HSF4 and GFP vector were
co-transfected into HLECs with FLAG-tagged p53. The cell extraction was immunoprecipitated with the indicated tag antibody and analyzed by immunoblotting with the other tag anti-
body. TheGFP antibodywasused to IP in theupper panels, and the FLAG antibody in themiddle panels. Immunoblotting of the expression of heterogeneousGFP-HSF4 and FLAG-p53 in the
lower panels, GAPDH is indicated for loading control. * Indicates heterogenous IgG band.
1813M. Huang et al. / Biochimica et Biophysica Acta 1853 (2015) 1808–1817with other cells. The half-life of p53 was remarkably extended in HSF4
transfected cells compared with that in vector control, suggesting that
p53was stabilized inHSF4-transfected cells (Fig. 5A). In contrast, all cat-
aract causative mutants (A20D, R74H and L115P) extended the half-life
of p53 protein in a slight degree compared to control (Fig. 5B).We con-
ﬁrmed that HSF4 wild type, but not mutants, stabilized p53. Corre-
spondingly, we found that p53 was degraded faster in HSF4 interfered
cells compared with control siRNA transfected cells (Fig. 5C, D).
Next, we tested whether the increased stability of p53 by HSF4 was
due to its reduced ubiquitin-related proteolysis. HLECs cells were
transfected with indicated expression plasmids, and treated with the
proteasome inhibitor, MG132 (10 μM), for 6 h. As depicted in Fig. 5E,
overexpression of HSF4, but not the cataract causative mutants (A20D,
R74H and L115P), inhibited the ubiquitination of p53 protein. As ex-
pected, wild type HSF4 decreased the ubiquitin modiﬁcation of p53remarkably, while the HSF4mutations failed to stop the ubiquitin mod-
iﬁcation process. These results indicated that HSF4 stabilized p53 by
inhibiting its ubiquitination.
3.6. HSF4 increased p53 transcriptional activity and enhanced p21
expression
The transcriptional activation of p53 is closely related to its stability.
Thus, we proposed that the increase of p53 protein levels caused by
HSF4 might elevate its transcriptional activation activity. Wild type
and mutant HSF4 were transiently co-transfected with a control plas-
mid renilla luciferase pRL-TK and a p53-Luc reporter plasmid that
contained the luciferase reporter gene driven by a basic promoter ele-
ment joined to 14 repeats of the p53 binding site. The p53 RE (response
element) luciferase activities were measured and normalized by renilla
Fig. 4.HSF4 up-regulates p53 protein level. (A)Overexpression of HSF4 increases p53 protein.WT andmutantHSF4 (A20D, R74H and L115P)were transfected intoHLECs. 24 h after trans-
fection, cells were collected for protein extraction. (B) p53 bands were quantiﬁed using densitometric analysis. The relative protein level was normalized by the GAPDH. The result was
shown in the histogram. Three independent experiments were performed. (C) Cells were collected for RNA extraction. The relative mRNA levels were normalized to β-actin. Three inde-
pendent experiments were performed. (D) Ablation of HSF4 reduces p53 protein. HLECswere transfectedwith two pairs of siRNA targeting HSF4 and NC. 48 h after transfection, p53 pro-
tein level was analyzed bywestern blot. (E) p53 bandswere quantiﬁed using densitometric analysis as shown in the histogram. (F) RNAwas extracted and qPCRwas performed to detect
the mRNA level of p53. The relative mRNA levels were normalized to β-actin. Three independent experiments were performed. *, p b 0.01. NS, not signiﬁcant.
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cantly increased the transcriptional activation activity of p53 (Fig. 6A).
Inspired by this result, we detected the expression of p53 target gene
p21. HLECs were transfected with HSF4 relevant plasmids or HSF4
siRNAs, and the p21 mRNA and protein levels were analyzed. Both the
mRNA and protein levels of p21 were increased when exogenous wild
type HSF4 was supplied, all the cataract causative mutants (A20D,
R74H and L115P) had no contribution to p21 expression (Fig. 6B–D).
As a complementary, both themRNA and protein levels of p21 were re-
ducedwith the decreasing of HSF4, thedecrease of p21proteinwas con-
sistent with mRNA level (Fig. 6E–G). The interference efﬁciency of
siRNAs against HSF4 was checked by qPCR (Fig. S6). This indicates
that wild type HSF4 can increase p21 at both mRNA and protein levels.
p21 is a key regulator of the cell cycle and can inhibit both the G1/S
and the G2/M phase transitions [41]. As it ﬂuntuates in accordance with
HSF4 status, we believed that HSF4 induced p21 expressionmight play a
role in HSF4-regulated HLECs cell cycle progression. In conclusion, our
data suggested that HSF4 blocks HLECs cell cycle by regulating the sta-
bility of p53, which activates its target gene p21. HSF4 cataract causing
mutants failed to activate p53 and promote p21 expression, leading to
the disturbance of the proliferation and differentiation of HLECs.
4. Discussion
HSFs family members, HSF1 and HSF2, can change the stability and
transcriptional activity of p53 [42]. Logan et al. demonstrated that
HSF1 can form a complex with nuclear p53, and both proteins are co-
operatively recruited to p53-responsive genes such as p21 and activate
these genes [40]. Here we describe that HSF4, another member of the
HSF family, can interactwith p53 and regulate its transcriptional activity
in HLECs. Our results open a new avenue towards understanding thenew function of HSF4 and also shed important light on the mechanism
of cataractogenesis caused by HSF4 mutations.
The p53 protein levels correlate with development and embryogen-
esis [43–45]. Early pre-B cell line L12, which lacks wild-type p53, main-
tains an undifferentiated state. Introduction of wild-type p53 into these
cells induces an increase in the fraction of cells in G0/G1 and triggers cell
differentiation [46]. In HLECs, we found that HSF4 up-regulates p53 by
increasing p53 stability, and inhibits cell growth by causing cell cycle ar-
rest. Inhibition of proliferation and cell cycle exit are both the necessary
steps for lens epithelial cell differentiation. In the developmental pro-
cess, the cells withdraw from the cell cycle, grow out in both the anteri-
or and posterior directions and ﬁnally form elongated ﬁber cells [47].
The HLECs that stay in G0/G1 stage may get ready to differentiate into
lens ﬁber cells, so it is essential for HLECs to withdraw from the cell
cycle. We ﬁnd that HSF4 but not its mutants up-regulates p53 and con-
trols the G1/S transition of HLECs.
The p53mRNA is not up-regulated byHSF4. However, the half-life of
p53 protein is remarkably extended by HSF4, compared with the mu-
tants. This was consistent with the ubiquitination assays. p53 is main-
tained at low levels in normal cells by Mdm2-mediated ubiquitination
and subsequent proteolysis [48–50]. The subtle regulation of p53 level
is primarily controlled by E3 ubiquitin protein ligase Mdm2 in the
adult mouse eye lens [51]. In the present study, we showed that HSF4
stabilizes the p53 protein. The HSF4 conjunction with p53 may change
the conformation of p53 protein required for Mdm2 binding. Also,
HSF4may play a role in the regulation of Mdm2 ubiquitin ligase activity
directly. It has been suggested that transcriptional activity of HSF4 is
inhibited by the interactionwith DAXX [52], which promotes the stabil-
ity of MDM2 through preventing its self-ubiquitination and enhancing
the intrinsic E3 activity towards p53 [53]. Therefore, we hypothesize
that HSF4 may stabilize p53 by regulating Mdm2.
Fig. 5.HSF4 enhances p53 stability by inhibiting its ubiquitination. (A)Myc taggedWT andmutant HSF4were transfected intoHLECs. 24 h after transfection, cellswere treatedwith 0.5 μg/
ml CHX at the indicated time. Then the total cell lysates were harvested and used for immunoblotting with antibodies against p53 and α-tubulin. (B) The intensity of p53 bands were
quantiﬁed using Quantity One software for densitometric analysis and a graph was plotted. Data represent percentages of p53 intensity of three independent experiments. (mean ±
S.D.). (C) Two pairs of siRNAs against HSF4 and NC were transfected into HLECs. 48 h after transfection, cells were treated with 0.5 μg/ml CHX at the indicated time. Cell lysates were an-
alyzed by western blot with antibodies against p53 and GAPDH. (D) The amount of p53 was normalized to GAPDH. Data represent percentages of p53 intensity of three independent ex-
periments (mean±S.D.). (E) HSF4 reduces p53 ubiquitination. Myc tagged HSF4 WT or mutant type vectors were transfected into HLECs. 36 h after transfection, MG132 (10 μM) was
added into cells for 6 h. Cell lysates were incubated with antibody against p53 and passed through the Protein G Sepharose beads. Eluted proteins were subjected to western blot
using antibody against UB (upper panel). Ubiquitylated p53 (Ub-p53) is indicated. The expression of total p53 and WT or mutant HSF4 is shown in lower two panels.
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fate, the dynamics of p53 is strictly monitored in cells. Subnuclear local-
ization of p53 is also very important for p53 activity. p53 can accumu-
late in promyelocytic leukemia (PML) nuclear body [54–56], which
may serve as a “meeting place” for p53 and its-interacting proteins. As
shown in Fig. 2, HSF4 but not its mutants sequesters p53 in the nucleus.
HSF4 co-localizes and interacts with p53 in the nucleus. HSF4 locates in
the nucleus in a peculiar pattern, yet the distribution of cataracts-
causing mutants A20D, R74H and L115P are dispersed. Whether the
PML is the “meeting place” of p53 and HSF4, however, requires further
study.
The activation of p53 by HSF4 may perform other functions in lens
besides epithelial cell differentiation. In our previous study, we found
that HSF4 promotes DNA damage repair through regulating Rad51 ex-
pression [36]. Studies unveiled that p53 regulates the homologous re-
combination via transcriptional repression of Rad51. Thus, the balance
of Rad51 level may be compromised by interaction between HSF4 and
p53, the latter of which plays an important role in response to DNA
damage during lens development and senile cataract formation. It has
been shown that the apoptosis or cell death of lens epithelial cells is a
signiﬁcant reason for congenital and senile cataract formation [57].
Further studies may elucidate the role of HSF4 in lens epithelial cell
apoptosis responding to various environmental stresses in the future.
Several lines of evidence demonstrated that elaborate control is
necessary on the differentiation from lens epithelial cells into lens
ﬁber cells, which requires inhibition of proliferation, cell cycle exit,expression of speciﬁc structural proteins, and degradation of nuclei
and organelles. HSF4 fulﬁlls a central role in controlling spatial and tem-
poral expression of genes critical for lens development and ﬁber cell
differentiation [10]. As a transcriptional factor, HSF4 was shown to reg-
ulate the expression of key lens speciﬁc genes such asαA-crystallin,αB-
crystallin, γS-crystallin, and lens-speciﬁc beaded ﬁlament proteins 1
and 2 (Bfsp1 and Bfsp2) as well [9,10,58]. Our previous data showed
HSF4 controlled lens differentiation through regulation of DLAD expres-
sion and activity, and de-nucleation of lens ﬁber cells during lens devel-
opment [59]. We have provided new evidence that HSF4 could work as
a switch between cell proliferation and cell differentiation during lens
development. HSF4 inhibits lens epithelial cell proliferation via G1/S ar-
rest dependent on p53, suggesting thatHSF4 plays a pivotal role in these
elaborative regulations.
To explore the pathologic mechanism regarding how mutations of
HSF4 cause cataract, we have conducted a series of molecular and
cellular studies and obtained novel ﬁndings. In conclusion, we have
described that HSF4 inhibits HLECs proliferation and inducing G1/S
arrest in a p53 dependent manner. Its cataract-causing mutations
(A20D, R74H and L115P) failed to withdraw the cell cycle progression.
HSF4 directly interacts with p53 protein and sequesters it in nucleus.
HSF4 stabilizes p53 protein by inhibits its ubiquitin degradation. Wild
type HSF4, but not its cataract-causing mutations, promotes the
accumulation and activation of p53, which could detain cells in G0/G1
phase by activating p21. Our data reveal that HSF4maywork as a switch
between lens epithelial cell proliferation and secondary ﬁber cell
Fig. 6.HSF4 increases p53 transcriptional activity and enhances p21 expression. (A) HSF4 increases p53 transcriptional activity. p53 transcriptional activity was assayed by reporter con-
struct p53 RE (p53 response element) -Luc, which was co-transfected with pRL-TK and HSF4 relevant plasmids. The luciferase activities of whole cell lysates weremeasured. Data are the
average of three replicate experiments. (B–D)HSF4 increases p21 both inmRNA and protein levels. (B)WT andmutant HSF4were transfected into HLECs for 24 h. p21mRNAwas assayed
by qPCR. The relative mRNA levels were normalized to β-actin. (C) Cells were collected for protein extraction. p21 protein levels were determined by western blot. (D) p21 bands were
quantiﬁed using densitometric analysis as shown in the histogram. The relative protein level was normalized by the GAPDH. Three independent experiments were performed. (E–G) Ab-
lation of HSF4 reduces p21mRNA and protein levels. HLECs were transfectedwith siRNAs directed against HSF4 and NC for 48 h. (E) p21mRNA levels were determined by qPCR and nor-
malized to β-actin. (F) p21 protein levelswere determined bywestern blot. (G) The relative protein levels of p21were quantiﬁed using densitometric analysis and normalized byGAPDH.
*, p b 0.01.
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pathogenic mechanisms caused by HSF4 mutations to a certain extent.
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